Rezolute, Inc. Files 8-K on Shareholder Votes & Financials

Ticker: RZLT · Form: 8-K · Filed: May 17, 2024 · CIK: 1509261

Rezolute, Inc. 8-K Filing Summary
FieldDetail
CompanyRezolute, Inc. (RZLT)
Form Type8-K
Filed DateMay 17, 2024
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: corporate-actions, financial-reporting, filing-update

TL;DR

Rezolute filed an 8-K covering shareholder votes and financials, with a history of name changes.

AI Summary

Rezolute, Inc. filed an 8-K on May 17, 2024, reporting on matters submitted to a vote of security holders and financial statements. The filing also notes the company's former names, AntriaBio, Inc. and FITS MY STYLE INC, with name changes occurring on January 14, 2013, and January 4, 2011, respectively. The principal executive offices are located at 275 Shoreline Drive, Suite 500, Redwood City, CA 94065.

Why It Matters

This filing provides updates on important corporate actions and financial reporting for Rezolute, Inc., which can impact investor decisions.

Risk Assessment

Risk Level: low — This is a routine filing for corporate actions and financial reporting, not indicating immediate operational or financial distress.

Key Players & Entities

  • Rezolute, Inc. (company) — Registrant
  • AntriaBio, Inc. (company) — Former company name
  • FITS MY STYLE INC (company) — Former company name
  • May 16, 2024 (date) — Earliest event reported date
  • May 17, 2024 (date) — Filing date
  • 275 Shoreline Drive, Suite 500, Redwood City, CA 94065 (location) — Principal executive offices address

FAQ

What specific matters were submitted to a vote of security holders?

The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in the excerpt.

What financial statements are included in this filing?

The filing lists 'Financial Statements and Exhibits' as an item, but the specific financial statements are not detailed in the provided text.

When did Rezolute, Inc. change its name from AntriaBio, Inc.?

Rezolute, Inc. changed its name from AntriaBio, Inc. on January 14, 2013.

What is the company's principal executive office address?

The company's principal executive offices are located at 275 Shoreline Drive, Suite 500, Redwood City, CA 94065.

What is the Commission File Number for Rezolute, Inc.?

The Commission File Number for Rezolute, Inc. is 001-39683.

Filing Stats: 679 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2024-05-17 16:21:45

Key Financial Figures

  • $0.001 — ch registered Common Stock, par value $0.001 per share RZLT Nasdaq Capital Market

Filing Documents

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. Rezolute, Inc. (the "Company") held its 2024 annual meeting of stockholders on May 16, 2024. The meeting was held virtually at RZLT (issuerdirect.com) . As of the record date, March 18, 2024, there were a total of 40,127,647 shares of common stock outstanding and entitled to vote at the special meeting. At the annual meeting, 27,494,377 shares of common stock were represented in person (virtually) or by proxy; therefore, a quorum was present. The final voting results for the matters submitted to a vote of stockholders were as follows: Proposal No. 1 - Election of Directors To elect the following nominees to serve as members of the Company's board of directors: Nominee Name Votes For Votes Withheld Broker Non Votes Young-Jin Kim 26,867,423 195,232 431,722 Nevan Charles Elam 27,027,137 35,518 431,722 Philippe Fauchet 26,839,313 223,342 431,722 Gil Labrucherie 26,909,378 153,277 431,722 Wladimir Hogenhuis 26,839,313 223,342 431,722 Nerissa Kreher 26,839,040 223,615 431,722 Proposal No. 2 - Ratification of Independent Registered Public Accounting Firm To ratify Grant Thornton LLP as the Company's independent registered public accounting firm for fiscal year 2024: Votes For Votes Against Abstentions Broker Non Votes 27,350,525 3,686 140,166 431,722 Proposal No. 3 - Say-on-Pay Proposal To approve by a non-binding advisory vote, the compensation of the Company's named executive officers, as disclosed in the Executive Compensation section of the proxy statement: Votes For Votes Against Abstentions Broker Non Votes 26,684,240 225,756 152,659 431,722 Proposal No. 4 - Equity Plan Amendment Proposal To approve an amendment to the Company's 2021 Stock Incentive Plan to reflect the adoption of the Company's incentive compensation recovery policy: Votes For Votes Against Abstentions Broker Non Votes 26,551,450.000 338,688 172,517 431,722

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following Exhibits are furnished as part of this Current Report on Form 8-K. Exhibit No. Description 104 Cover Page Interactive Data File (formatted as inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REZOLUTE, INC. DATE: May 17, 2024 By: /s/ Nevan Elam Nevan Elam Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.